In2Care® EaveTube Trial shows almost 40% reduction in malaria cases

Project PI Prof. Matt Thomas and partners from the Institut Pierre Richet recently shared results of the In2Care EaveTube Randomized Control Trial to government officials in Abidjan, Ivory Coast. They shared that malaria case incidence was reduced by 38% in villages that had the In2Care EaveTube intervention in comparison to control villages that received only bednets. A community effect was also demonstrated when the intervention coverage was above 60%. Dr. Raphael N’Guessan revealed that the highly resistant mosquito population was halved, and that the Entomological Inoculation Rate was reduced with 60%. Social science results showed high user acceptance; over 90% of residents liked the impact of In2Care EaveTubes and wanted to keep using the product.

In2Care Mosquito Trap

A multi-impact tool against mosquitoes that transmit Dengue, Chikungunya, Yellow Fever and Zika virus.

Kills (even insecticide-resistant) Aedes mosquitoes
Kills mosquito larvae and pupae (inside trap & in surroundings)
Reduces the risk of mosquito-borne virus transmission
Field validated & published results
Uses safe ingredients and is environmentally friendly

Learn More

Eave Tubes

A novel and resistance-breaking malaria mosquito control product developed by In2Care.

Easy-to-install tubes + removable gauze inserts
Blocks mosquitoes from entering the house
Effective against insecticide-resistant vectors
A safe product that protects the whole family
Evaluated in field trials supported by EU FP7, the Bill & Melinda Gates Foundation & HDIF

Learn More

The In2Care Mosquito Trap

The In2Care Mosquito Trap is currently being sold to governments, pest control operators and mosquito abatement districts in >30 countries worldwide. The product is US-EPA registered (EPA reg no. 91720-1) and allowed for professional use against Aedes mosquitoes. Sales and distribution in the US and other countries in the Americas is organized via our US-based distributor Univar Environmental Sciences: http://pestweb.com/in2care-trading.

Registration processes in several other countries are ongoing. In2Care has partnered with Ensystex and AustralAsian Biosecurity to enable trap distribution in Asia and the Pacific.

The In2Care Mosquito Trap lures and contaminates Aedes mosquitoes with a special slow-killing larvicide and let them spread this to other breeding sites (which are often hard to find and treat) so that mosquito larvae are not only killed inside the trap but also in its vicinity. This is combined with a biological adulticide that kills the contaminated mosquito after a few days to prevent her from transmitting any viruses like Dengue or Zika virus. In this way, the product kills the mosquitoes and their offspring, so that populations are reduced and disease transmission risks are lowered significantly. Click to open our detailed In2Care Mosquito Trap information factsheets in English, Spanish, Portuguese and French.

The efficacy has been demonstrated by scientific studies published in Parasites & Vectors and the Journal of the American Mosquito Control Association (click to open).

The In2Care Mosquito Trap is made of easy to assemble and durable components, and uses water & refill sachets with EPA-registered bioactives for monthly reactivation. The product should be placed around homes, hotels, hospitals and other outdoor settings in shaded and vegetated sites where there is a lot of Aedes mosquito breeding. With high enough coverage (10 traps per acre) this product will reduce Aedes populations after 2-3 weeks by killing them and their offspring in and around the traps. The novel mode of action can complement other vector control efforts and the traps are ideal for hotspots and problem areas where insecticide use is restricted or hampered by chemical resistance.

Trap installation and monthly maintenance instructions are described in our User Manual and product videos.

Now available in the US